SCHEMBL14496002

SCHEMBL14496002

CCc1ccccc1-c1ccc(C)cc1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 1/20 0.50
CSNK2B P67870 1/20 0.50
CSNK2A1 P68400 1/20 0.50
CSNK2A3 Q8NEV1 1/20 0.50
ELANE P08246 1/20 0.47
DHFR P00374 1/20 0.47
MAPT P10636 4/20 0.41
MAPK1 P28482 4/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
GAA P10253 1/20 0.41
KDM4E B2RXH2 1/20 0.41
TRPA1 O75762 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
MAPK10 P53779 1/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
RAB9A P51151 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14492841 0.85 ELANE (0.47) CSNK2A2CSNK2BCSNK2A1CSNK2A3ELANE
SCHEMBL9776402 0.85 ELANE (0.47) CSNK2A2CSNK2BCSNK2A1CSNK2A3ELANE
SCHEMBL8409184 0.83 ELANE (0.46) CSNK2A2CSNK2BCSNK2A1CSNK2A3ELANE
SCHEMBL9307469 0.82 ELANE (0.42) ELANEMAPTMAPK1GAASMN1; SMN2
SCHEMBL23862755 0.81 CSNK2A2 (0.55) CSNK2A2CSNK2BCSNK2A1CSNK2A3DHFR
SCHEMBL5599467 0.81 CSNK2A2 (0.49) CSNK2A2CSNK2BCSNK2A1CSNK2A3DHFR
SCHEMBL5849852 0.80 ELANE (0.39) CSNK2A2CSNK2BCSNK2A1CSNK2A3ELANE
SCHEMBL11875210 0.79 L3MBTL1 (0.45) MAPTL3MBTL1GAAKDM4ESMN1; SMN2
SCHEMBL29590360 0.79 ELANE (0.52) ELANEDHFRMAPTMAPK1L3MBTL1
SCHEMBL11729295 0.79 ELANE (0.52) ELANEDHFRMAPTMAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007071456-A1 FLUORENES AND CARBAZOLES AS LIGANDS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-06-28 WO disclosed